What is the regulatory perspective on the RheaLyo cake shape?
RheaVita has already shared processed product with the FDA and EMA. Regulatory bodies are
enthusiastic about the continuous manufacturing aspect of the RheaLyo technology. The cake aspect is not a concern. The agencies focus on reproducibility and drug or vaccine CQAs.
enthusiastic about the continuous manufacturing aspect of the RheaLyo technology. The cake aspect is not a concern. The agencies focus on reproducibility and drug or vaccine CQAs.